![The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing | mBio The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing | mBio](https://journals.asm.org/cms/10.1128/mBio.00812-17/asset/ddba55f3-1f5e-4bdc-bdfc-73df9e939300/assets/graphic/mbo0041734530002.jpeg)
The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing | mBio
![Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study - The Lancet Respiratory Medicine Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/e9255e00-af6e-49b1-bb5b-13ee417bfa94/gr2_lrg.jpg)
Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study - The Lancet Respiratory Medicine
Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection | PLOS ONE
![Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study - The Lancet Respiratory Medicine Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/95702542-1850-4f73-aa76-917ea1800dc9/gr1b.gif)